| Application number | Title of the application | Filing Date | Status |
|---|
| 08/967242 | ANTIGEN-SPECIFIC, ACTIVATED T LYMPHOCYTES, DETECTION AND USE | Nov 4, 1997 | Abandoned |
| 08/962497 | METHODS AND COMPOSITIONS COMPRISING GLYCOPROTEIN GLYCOFORMS | Oct 30, 1997 | Abandoned |
| 08/918349 | PROCESS FOR INHIBITING COMPLEMENT ACTIVATION VIA THE ALTERNATIVE PATHWAY | Aug 25, 1997 | Abandoned |
| 08/920185 | ANTIBODIES TO POLYSACCHARIDE OF C. NEOFORMANS | Aug 24, 1997 | Abandoned |
Array
(
[id] => 3940515
[patent_doc_number] => 05973122
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-26
[patent_title] => 'Serum immunoregulatory polypeptides and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 8/891056
[patent_app_country] => US
[patent_app_date] => 1997-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7645
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/973/05973122.pdf
[firstpage_image] =>[orig_patent_app_number] => 891056
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/891056 | Serum immunoregulatory polypeptides and uses therefor | Jul 9, 1997 | Issued |
Array
(
[id] => 4089938
[patent_doc_number] => 06096314
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-01
[patent_title] => 'Peptides and pharmaceutical compositions comprising them'
[patent_app_type] => 1
[patent_app_number] => 8/817177
[patent_app_country] => US
[patent_app_date] => 1997-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 13118
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/096/06096314.pdf
[firstpage_image] =>[orig_patent_app_number] => 817177
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/817177 | Peptides and pharmaceutical compositions comprising them | Jun 29, 1997 | Issued |
Array
(
[id] => 4218890
[patent_doc_number] => 06111071
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-29
[patent_title] => 'Recombinant fusion protein comprising PDC-E2, BCOADC-E2 and OGDC-E2 and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/881771
[patent_app_country] => US
[patent_app_date] => 1997-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 7
[patent_no_of_words] => 9757
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/111/06111071.pdf
[firstpage_image] =>[orig_patent_app_number] => 881771
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/881771 | Recombinant fusion protein comprising PDC-E2, BCOADC-E2 and OGDC-E2 and uses thereof | Jun 23, 1997 | Issued |
| 08/860037 | PRODUCTION OF RECOMBINANT SECRETORY COMPONENT | Jun 10, 1997 | Abandoned |
Array
(
[id] => 4007891
[patent_doc_number] => 05962319
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-05
[patent_title] => 'Human-Th1-specific protein, gene encoding the protein, transformants, recombinant vectors, and antibodies related to the gene'
[patent_app_type] => 1
[patent_app_number] => 8/869793
[patent_app_country] => US
[patent_app_date] => 1997-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12511
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/962/05962319.pdf
[firstpage_image] =>[orig_patent_app_number] => 869793
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/869793 | Human-Th1-specific protein, gene encoding the protein, transformants, recombinant vectors, and antibodies related to the gene | Jun 4, 1997 | Issued |
| 08/836530 | ANTIBODIES AGAINST ALLOGENIC AND XENOGENIC PROTEINS,THEIR USE IN DIAGNOSIS AND THERAPY AND METHODS FOR THE DETERMINATION THEREOF | May 1, 1997 | Abandoned |
Array
(
[id] => 3953676
[patent_doc_number] => 05935797
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-10
[patent_title] => 'Interaction of MHC Class II proteins with members of the PCNA family of proteins'
[patent_app_type] => 1
[patent_app_number] => 8/829132
[patent_app_country] => US
[patent_app_date] => 1997-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5972
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 242
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/935/05935797.pdf
[firstpage_image] =>[orig_patent_app_number] => 829132
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/829132 | Interaction of MHC Class II proteins with members of the PCNA family of proteins | Mar 27, 1997 | Issued |
Array
(
[id] => 4023647
[patent_doc_number] => 05993813
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-30
[patent_title] => 'Family of high affinity, modified antibodies for cancer treatment'
[patent_app_type] => 1
[patent_app_number] => 8/822028
[patent_app_country] => US
[patent_app_date] => 1997-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 41
[patent_no_of_words] => 42522
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/993/05993813.pdf
[firstpage_image] =>[orig_patent_app_number] => 822028
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/822028 | Family of high affinity, modified antibodies for cancer treatment | Mar 23, 1997 | Issued |
Array
(
[id] => 3986136
[patent_doc_number] => 05959087
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-28
[patent_title] => 'Tumour necrosis factor binding ligands'
[patent_app_type] => 1
[patent_app_number] => 8/823893
[patent_app_country] => US
[patent_app_date] => 1997-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 35
[patent_no_of_words] => 13625
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/959/05959087.pdf
[firstpage_image] =>[orig_patent_app_number] => 823893
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/823893 | Tumour necrosis factor binding ligands | Mar 16, 1997 | Issued |
Array
(
[id] => 3931565
[patent_doc_number] => 05928901
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-27
[patent_title] => 'Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum in hepatocytes and compositions containing them'
[patent_app_type] => 1
[patent_app_number] => 8/760000
[patent_app_country] => US
[patent_app_date] => 1996-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7452
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 660
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/928/05928901.pdf
[firstpage_image] =>[orig_patent_app_number] => 760000
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/760000 | Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum in hepatocytes and compositions containing them | Dec 2, 1996 | Issued |
| 08/753615 | HLA BINDING PEPTIDES AND THEIR USES | Nov 26, 1996 | Abandoned |
| 08/758409 | HLA BINDING PEPTIDES AND THEIR USES | Nov 26, 1996 | Abandoned |
Array
(
[id] => 4041568
[patent_doc_number] => 05911991
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-15
[patent_title] => 'Malarial binding site in duffy blood group protein'
[patent_app_type] => 1
[patent_app_number] => 8/749526
[patent_app_country] => US
[patent_app_date] => 1996-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9437
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/911/05911991.pdf
[firstpage_image] =>[orig_patent_app_number] => 749526
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/749526 | Malarial binding site in duffy blood group protein | Nov 14, 1996 | Issued |
| 08/741530 | IMMUNE MODULATION WITH CLASS II ALPHA-CHAIN FRAGMENTS | Oct 30, 1996 | Abandoned |
Array
(
[id] => 4001394
[patent_doc_number] => 06004758
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-21
[patent_title] => 'Receptor derived peptides involved in modulation of response to ligand binding'
[patent_app_type] => 1
[patent_app_number] => 8/701382
[patent_app_country] => US
[patent_app_date] => 1996-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7419
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/004/06004758.pdf
[firstpage_image] =>[orig_patent_app_number] => 701382
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/701382 | Receptor derived peptides involved in modulation of response to ligand binding | Aug 21, 1996 | Issued |
Array
(
[id] => 4041554
[patent_doc_number] => 05911990
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-15
[patent_title] => 'T-cell receptor peptides and methods for preventing the progression to AIDS in an animal model'
[patent_app_type] => 1
[patent_app_number] => 8/696049
[patent_app_country] => US
[patent_app_date] => 1996-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10908
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/911/05911990.pdf
[firstpage_image] =>[orig_patent_app_number] => 696049
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/696049 | T-cell receptor peptides and methods for preventing the progression to AIDS in an animal model | Aug 12, 1996 | Issued |
